Candel Therapeutics Appoints Maria Ostrovsky as General Counsel
Candel Therapeutics appointed Maria Ostrovsky as General Counsel, effective November 3, 2026, overseeing legal, compliance, and corporate governance. Ostrovsky brings 20 years of life-sciences legal experience, most recently as SVP, GC and Chief Compliance Officer at Deciphera Pharmaceuticals, with prior roles at TESARO and Takeda supporting global oncology launches.
Key figures
- Effective date
- November 3, 2026
- Bla submission timing
- Q4 2026
- Years legal experience
- 20
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.